Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    0.20 (0.28%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.58m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Annual Overview from QuotedData

10 Jul 2025 14:48

RNS Number : 6102Q
Geiger Counter Ltd
10 July 2025
 

Geiger Counter Limited - Annual Overview from QuotedData

10th July 2025

Enriched prospects

A commitment to quadruple nuclear generating capacity in the US, made by President Donald Trump in a series of executive orders signed at the end of May, has provided a significant and much-needed boost to the uranium sector, in which Geiger Counter (GCL) invests. A number of uranium stocks rose by double figures in the days following the pledge to "re-establish the US as a global leader in nuclear energy".

Investor sentiment towards the sector had been waning prior to this, with a number of factors combining to put downward pressure on GCL's net asset value (NAV) (which we explore on page 4). In reality, this was in stark contrast to the fundamentals of the uranium market, which is displaying both demand-side expansion (increasing energy needs, especially from countries seeking lower-emission baseload power) and supply-side constraints. The expertise and long-term track record of GCL's manager, along with the extremely positive market fundamentals, make it an opportune time to invest in the company.

Full Research:

https://quoteddata.com/research/geiger-counter-limited-enriched-prospects-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Geiger Counter Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADXEFLKSEFA
Date   Source Headline
1st Jul 20257:31 amRNSEntry into Standstill Agreement
30th Jun 20255:22 pmRNSRelease of Interim Report and Financial Statements
30th Jun 20253:30 pmRNSNet Asset Value(s)
30th Jun 20259:02 amRNSTransaction in Own Shares
27th Jun 20254:09 pmRNSNet Asset Value(s)
26th Jun 20254:58 pmRNSNet Asset Value(s)
26th Jun 20259:53 amRNSShare Buyback
25th Jun 20251:24 pmRNSNet Asset Value(s)
24th Jun 202512:47 pmRNSNet Asset Value(s)
23rd Jun 20251:31 pmRNSNet Asset Value(s)
23rd Jun 20259:36 amRNSShare Buyback
20th Jun 20253:35 pmRNSMonthly Factsheet- May 2025
20th Jun 20251:10 pmRNSNet Asset Value(s)
19th Jun 202512:08 pmRNSNet Asset Value(s)
19th Jun 20259:48 amRNSHolding(s) in Company
18th Jun 20253:36 pmRNSNet Asset Value(s)
17th Jun 20251:13 pmRNSNet Asset Value(s)
16th Jun 20252:04 pmRNSNet Asset Value(s)
16th Jun 202512:35 pmRNSShare Buyback
13th Jun 20251:23 pmRNSNet Asset Value(s)
12th Jun 202512:59 pmRNSNet Asset Value(s)
11th Jun 202511:56 amRNSNet Asset Value(s)
11th Jun 202510:02 amRNSShare Buyback
10th Jun 20254:46 pmRNSNet Asset Value(s)
9th Jun 20253:27 pmRNSNet Asset Value(s)
9th Jun 20251:59 pmRNSTotal Voting Rights- May 2025
9th Jun 20259:38 amRNSShare Buyback
6th Jun 20251:45 pmRNSNet Asset Value(s)
6th Jun 202510:50 amRNSHolding(s) in Company
6th Jun 20258:05 amRNSShare Buyback
5th Jun 20251:08 pmRNSNet Asset Value(s)
5th Jun 202511:45 amRNSHolding(s) in Company
5th Jun 202511:30 amRNSHolding(s) in Company
4th Jun 20251:06 pmRNSNet Asset Value(s)
3rd Jun 20253:41 pmRNSNet Asset Value(s)
2nd Jun 20254:02 pmRNSNet Asset Value(s)
2nd Jun 20259:20 amRNSShare Buyback
30th May 20255:03 pmRNSNet Asset Value(s)
30th May 202510:47 amRNSShare Buyback
29th May 202512:42 pmRNSNet Asset Value(s)
28th May 20255:09 pmRNSHolding(s) in Company
28th May 20251:57 pmRNSNet Asset Value(s)
27th May 20253:17 pmRNSNet Asset Value(s)
23rd May 20253:35 pmRNSNet Asset Value(s)
22nd May 20254:22 pmRNSNet Asset Value(s)
22nd May 202510:55 amRNSMonthly Factsheet- April 2025
21st May 20253:25 pmRNSNet Asset Value(s)
21st May 20257:39 amRNSHolding(s) in Company
20th May 20253:41 pmRNSNet Asset Value(s)
19th May 20254:12 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.